Ysios news
23.04.14
Kala Pharmaceuticals Announces $22.5 Million Series B Financing
19.03.14
Ysios Capital begins fundraising for Ysios Biofund II
portfolio news
01.07.14
European Medicines Agency renews Marketing Authorisation for ChondroCelect
30.06.14
TiGenix announces the clinical development of Cx611 in early rheumatoid arthritis and severe sepsis